BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 26134258)

  • 1. Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula.
    Chow CY; Cristofori-Armstrong B; Undheim EA; King GF; Rash LD
    Toxins (Basel); 2015 Jun; 7(7):2494-513. PubMed ID: 26134258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens.
    Cardoso FC; Dekan Z; Rosengren KJ; Erickson A; Vetter I; Deuis JR; Herzig V; Alewood PF; King GF; Lewis RJ
    Mol Pharmacol; 2015 Aug; 88(2):291-303. PubMed ID: 25979003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of ProTx-I and the novel venom peptide Pe1b provide insight into residues responsible for selective inhibition of the analgesic drug target Na
    Rupasinghe DB; Herzig V; Vetter I; Dekan Z; Gilchrist J; Bosmans F; Alewood PF; Lewis RJ; King GF
    Biochem Pharmacol; 2020 Nov; 181():114080. PubMed ID: 32511987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Spider (
    Gonçalves TC; Lesport P; Kuylle S; Stura E; Ciolek J; Mourier G; Servent D; Bourinet E; Benoit E; Gilles N
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31443554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical Synthesis, Proper Folding, Na
    Nicolas S; Zoukimian C; Bosmans F; Montnach J; Diochot S; Cuypers E; De Waard S; Béroud R; Mebs D; Craik D; Boturyn D; Lazdunski M; Tytgat J; De Waard M
    Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31234412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulatory features of the novel spider toxin μ-TRTX-Df1a isolated from the venom of the spider Davus fasciatus.
    Cardoso FC; Dekan Z; Smith JJ; Deuis JR; Vetter I; Herzig V; Alewood PF; King GF; Lewis RJ
    Br J Pharmacol; 2017 Aug; 174(15):2528-2544. PubMed ID: 28542706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational Engineering Defines a Molecular Switch That Is Essential for Activity of Spider-Venom Peptides against the Analgesics Target NaV1.7.
    Klint JK; Chin YK; Mobli M
    Mol Pharmacol; 2015 Dec; 88(6):1002-10. PubMed ID: 26429937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa
    Neff RA; Flinspach M; Gibbs A; Shih AY; Minassian NA; Liu Y; Fellows R; Libiger O; Young S; Pennington MW; Hunter MJ; Wickenden AD
    J Biol Chem; 2020 Jan; 295(5):1315-1327. PubMed ID: 31871053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. µ-TRTX-Ca1a: a novel neurotoxin from Cyriopagopus albostriatus with analgesic effects.
    Zhang YX; Peng DZ; Zhang QF; Huang B; Yang QC; Tang DF; Chen MZ; Rong MQ; Liu ZH
    Acta Pharmacol Sin; 2019 Jul; 40(7):859-866. PubMed ID: 30382183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seven novel modulators of the analgesic target NaV 1.7 uncovered using a high-throughput venom-based discovery approach.
    Klint JK; Smith JJ; Vetter I; Rupasinghe DB; Er SY; Senff S; Herzig V; Mobli M; Lewis RJ; Bosmans F; King GF
    Br J Pharmacol; 2015 May; 172(10):2445-58. PubMed ID: 25754331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the interaction site for the tarantula toxin hainantoxin-IV (β-TRTX-Hn2a) in the voltage sensor module of domain II of voltage-gated sodium channels.
    Cai T; Luo J; Meng E; Ding J; Liang S; Wang S; Liu Z
    Peptides; 2015 Jun; 68():148-56. PubMed ID: 25218973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V.
    Moyer BD; Murray JK; Ligutti J; Andrews K; Favreau P; Jordan JB; Lee JH; Liu D; Long J; Sham K; Shi L; Stöcklin R; Wu B; Yin R; Yu V; Zou A; Biswas K; Miranda LP
    PLoS One; 2018; 13(5):e0196791. PubMed ID: 29723257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potency optimization of Huwentoxin-IV on hNav1.7: a neurotoxin TTX-S sodium-channel antagonist from the venom of the Chinese bird-eating spider Selenocosmia huwena.
    Revell JD; Lund PE; Linley JE; Metcalfe J; Burmeister N; Sridharan S; Jones C; Jermutus L; Bednarek MA
    Peptides; 2013 Jun; 44():40-6. PubMed ID: 23523779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation, synthesis and characterization of ω-TRTX-Cc1a, a novel tarantula venom peptide that selectively targets L-type Cav channels.
    Klint JK; Berecki G; Durek T; Mobli M; Knapp O; King GF; Adams DJ; Alewood PF; Rash LD
    Biochem Pharmacol; 2014 May; 89(2):276-86. PubMed ID: 24561180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel.
    Murray JK; Ligutti J; Liu D; Zou A; Poppe L; Li H; Andrews KL; Moyer BD; McDonough SI; Favreau P; Stöcklin R; Miranda LP
    J Med Chem; 2015 Mar; 58(5):2299-314. PubMed ID: 25658507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and mode of action of a novel analgesic β-toxin from the African spider Ceratogyrus darlingi.
    Sousa SR; Wingerd JS; Brust A; Bladen C; Ragnarsson L; Herzig V; Deuis JR; Dutertre S; Vetter I; Zamponi GW; King GF; Alewood PF; Lewis RJ
    PLoS One; 2017; 12(9):e0182848. PubMed ID: 28880874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering of highly potent and selective HNTX-III mutant against hNa
    Zhang Y; Wang L; Peng D; Zhang Q; Yang Q; Li J; Li D; Tang D; Chen M; Liang S; Liu Y; Wang S; Liu Z
    J Biol Chem; 2021; 296():100326. PubMed ID: 33493520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determinant for the tarantula toxin Jingzhaotoxin-I slowing the fast inactivation of voltage-gated sodium channels.
    Tao H; Chen X; Lu M; Wu Y; Deng M; Zeng X; Liu Z; Liang S
    Toxicon; 2016 Mar; 111():13-21. PubMed ID: 26721415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure, dynamics and selectivity profile of a NaV1.7 potency-optimised huwentoxin-IV variant.
    Rahnama S; Deuis JR; Cardoso FC; Ramanujam V; Lewis RJ; Rash LD; King GF; Vetter I; Mobli M
    PLoS One; 2017; 12(3):e0173551. PubMed ID: 28301520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering Gain-of-Function Analogues of the Spider Venom Peptide HNTX-I, A Potent Blocker of the hNa
    Zhang Y; Yang Q; Zhang Q; Peng D; Chen M; Liang S; Zhou X; Liu Z
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30181499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.